- Home
- SHIP vs ELDN Comparison
SHIP vs ELDN Comparison
Compare SHIP & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- ELDN
- Stock Information
- Founded
- SHIP 2008
- ELDN 2004
- Country
- SHIP Greece
- ELDN United States
- Employees
- SHIP N/A
- ELDN N/A
- Industry
- SHIP Marine Transportation
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- SHIP Consumer Discretionary
- ELDN Health Care
- Exchange
- SHIP Nasdaq
- ELDN Nasdaq
- Market Cap
- SHIP 170.0M
- ELDN 164.1M
- IPO Year
- SHIP 2007
- ELDN N/A
- Fundamental
- Price
- SHIP $8.31
- ELDN $3.64
- Analyst Decision
- SHIP Strong Buy
- ELDN Strong Buy
- Analyst Count
- SHIP 1
- ELDN 2
- Target Price
- SHIP $11.00
- ELDN $12.50
- AVG Volume (30 Days)
- SHIP 141.4K
- ELDN 1.4M
- Earning Date
- SHIP 11-07-2025
- ELDN 11-11-2025
- Dividend Yield
- SHIP 9.23%
- ELDN N/A
- EPS Growth
- SHIP N/A
- ELDN N/A
- EPS
- SHIP 0.73
- ELDN 0.21
- Revenue
- SHIP $147,718,000.00
- ELDN N/A
- Revenue This Year
- SHIP N/A
- ELDN N/A
- Revenue Next Year
- SHIP $11.82
- ELDN N/A
- P/E Ratio
- SHIP $11.30
- ELDN $16.41
- Revenue Growth
- SHIP 1.66
- ELDN N/A
- 52 Week Low
- SHIP $4.78
- ELDN $2.32
- 52 Week High
- SHIP $10.16
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- SHIP 49.34
- ELDN 69.68
- Support Level
- SHIP $8.14
- ELDN $3.18
- Resistance Level
- SHIP $8.50
- ELDN $3.76
- Average True Range (ATR)
- SHIP 0.23
- ELDN 0.27
- MACD
- SHIP 0.01
- ELDN 0.06
- Stochastic Oscillator
- SHIP 61.90
- ELDN 83.06
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.